What if scientists could switch individual brain cells on and off with light?
That sounds like science fiction.
But it is now a reality in laboratories around the world — and the scientists who helped make it possible have just received the 2026 Nobel Prize in Physiology or Medicine.
American scientist Karl Deisseroth and German scientists Peter Hegemann and Georg Nagel have been jointly awarded the prize for their “discoveries concerning light-gated ion channels and optogenetics.”
Their research helped create a technique that allows scientists to use light to control the activity of individual nerve cells in a living brain.
The Nobel Assembly at Karolinska Institutet said their discoveries had “laid the foundation of a new era in neuroscience.”
So, what exactly is optogenetics?
Put simply, optogenetics allows scientists to control nerve cells using light.
Our brains contain billions of neurons that communicate with one another through electrical and chemical signals. For decades, scientists could observe which parts of the brain became active, but it was much harder to establish exactly what individual neurons or neural circuits were responsible for specific memories, emotions or behaviours.
Optogenetics changed that.
The technique combines genetics and light to make selected nerve cells sensitive to light. Scientists can then use pulses of light to activate or silence those cells with extraordinary precision.
That gives researchers something they had long wanted: a way to ask the brain much more precise questions.
What happens if this particular group of neurons switches on?
What happens if another group switches off?
Which cells are responsible for a particular behaviour?
And how do different circuits interact?
It started with a tiny organism and a very big question
The story behind the Nobel-winning breakthrough began with Peter Hegemann and an unusual question about a microscopic organism.
Hegemann was interested in Chlamydomonas, a single-celled green alga that can move towards a source of light.
He wanted to understand how the organism could detect light and use that information to control its movement.
Hegemann and Georg Nagel eventually identified a remarkable light-sensitive protein called channelrhodopsin.
The protein sits in a cell’s membrane. When blue light hits it, it opens a channel that allows charged ions to flow into the cell, creating an electrical signal.
The really important discovery came when the researchers found that the protein could make other types of cells respond to light as well.
That opened a door to something much bigger.
If scientists could put the light-sensitive protein into nerve cells, perhaps they could use light to control those neurons.
Then Karl Deisseroth took the idea into the brain
This is where Karl Deisseroth entered the story.
Deisseroth and his colleagues introduced the gene responsible for channelrhodopsin into nerve cells from rats.
When they exposed those cells to blue light, they were able to trigger a nerve signal. Deisseroth published this breakthrough in 2005.
Two years later, he demonstrated that the same light-controlled mechanism could work inside the brains of living mice.
That was a major turning point.
Scientists were no longer simply observing brain activity.
They had a tool that could manipulate specific nerve cells and neural circuits while an animal was alive.
The technique became known as optogenetics.
Why is this such a big deal?
Before optogenetics, researchers had methods for stimulating the brain, but many were relatively broad.
Imagine trying to understand a city’s traffic system by switching off an entire neighbourhood and seeing what happens.
You might learn something.
But you would not know which particular road caused the change.
Optogenetics gives scientists something closer to a precision switch.
They can target particular neurons or groups of neurons and observe what happens when those cells are activated or silenced.
This has allowed researchers to investigate neural circuits involved in memory, emotions, behaviour and neurological and psychiatric disorders.
As Nobel Committee chair Per Svenningsson put it:
“Optogenetics provides opportunities for mapping the brain in a way that we could once only dream of.”
Could this eventually help treat diseases?
The Nobel-winning discovery is primarily a research technology, but its medical potential is already being explored.
One particularly striking area is vision restoration.
Researchers are investigating optogenetic approaches for people who have lost their sight because of conditions such as retinitis pigmentosa. The idea is to introduce light-sensitive proteins into retinal cells so that they can once again respond to light.
Researchers are also exploring whether similar approaches could eventually improve technologies such as cochlear implants by allowing more precise stimulation of the auditory system.
These applications are still an area of active research. The Nobel Prize recognises the foundational scientific discoveries that made such work possible, rather than declaring optogenetics a finished treatment for these conditions.
A new way to study the brain
The brain remains one of science’s biggest mysteries.
Scientists know an enormous amount about its structure, chemistry and electrical activity, but understanding exactly how those components produce memories, emotions, decisions and behaviour remains extraordinarily difficult.
Optogenetics has given neuroscience a powerful new way to investigate those questions.
By controlling specific neurons with light, researchers can begin establishing cause and effect rather than simply observing correlations.
That is why the Nobel Committee says the technique has fundamentally changed our understanding of the brain.
Who are the three Nobel winners?
Karl Deisseroth
Karl Deisseroth, 54, is an American scientist and professor at Stanford University. His work helped transform channelrhodopsin from a biological discovery into a practical method for controlling nerve cells with light.
His experiments demonstrated that light could trigger nerve signals and later control neurons inside living animals.
Peter Hegemann
Peter Hegemann, 71, is a German neuroscientist at Humboldt University of Berlin.
His curiosity about how single-celled algae detect light led to the discovery of the biological mechanism that ultimately became the foundation of optogenetics.
Georg Nagel
Georg Nagel, 73, is a German scientist at the University of Würzburg.
Working with Hegemann, Nagel helped identify and characterise channelrhodopsin, the light-sensitive protein that became central to the development of optogenetics.
The three scientists will share ₹10 crore-plus
The laureates will share a Nobel prize amount of 12 million Swedish kronor, equivalent to roughly US$1.2 million.
The award was announced on October 5, 2026, at the Karolinska Institutet in Stockholm, marking the beginning of this year’s Nobel Prize announcements.
From algae to the human brain
There is something almost extraordinary about the path this discovery took.
It began with a scientist wondering how a single-celled alga moves towards light.
That led to the discovery of a light-sensitive protein.
That protein became a tool for controlling nerve cells.
And that tool is now allowing scientists to investigate how the brain produces memories, emotions and behaviour — and potentially develop new approaches for treating disease.
The 2026 Nobel Prize in Physiology or Medicine is therefore not simply about a new laboratory technique.
It is about giving scientists something they have desperately needed for generations:
a way to switch individual pieces of the brain on and off — and finally watch what happens.
Sources: Nobel Prize, Karolinska Institutet, Reuters, Associated Press and Nature.
